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Background
Lentiviruses with their ability to produce high virus titers
and to efficiently infect undividing mammalian cells rep-
resent an ideal platform for the display and directed evo-
lution of envelope proteins. A lentiviral display enables
the presentation of envelope protein complexes in a natu-
ral membrane environment both with a correct folding
pattern and oligomerisation.
Methods
Therefore, we developed a reciprocal system of a full-
length HIV packaging cell line and a shortened HI-viral
shuttle vector. The Tat-deficient packaging construct is sta-
bly integrated in a VSVG-pseudotyped cell line and trans-
activated by the shuttle vector by expression of TATGFP
from a heterologous promoter which also indicates posi-
tive cells. Expression of the HI-viral structure proteins is
driven by a natural 5' LTR promoter and a 3' polyadenyla-
tion signal, whereas the envelope expression out of the
shuttle vector is achieved by an IRES. This system of two
vectors is tightly controllable and bypasses the problem of
limited packaging capacity into HIV-1 virions.
Results
Transactivation of the packaging construct by the shuttle
vector resulted in particle release at 80% of wt HIV level.
We observed only 13% incorporation of packaging con-
struct RNA in viral particles but a highly efficient packag-
ing of the shuttle vector RNA. Replication of the shuttle
vector in the complementing packaging cell line resulted
in titers up to 1,1 × 107 IU/ml after ultracentrifugation,
and efficient infection of mammalian cells could be
achieved with resulting virus. Furthermore, we were able
to show a high transgene envelope expression which was
even increased relative to expression driven by the natural
Env ORF.
Conclusion
This vector system offers a platform for the viral display of
envelope antigens in a highly controllable manner and
will be used to affinity-mature envelope antigens by the
use of neutralizing antibodies against HIV-1.
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